Evidence map›Paper›PMID 41193722›Full record

ReviewCommunications biology2025

Integrating allostasis and emerging technologies to study complex diseases.

InWha Park, Hyokyeong Gwon, Yeonjeong Jung, Boyoung Kim, Gaeun Ju, Eugene Sin, Hye In An, Hye Jung Bang, Taegwan Yun, Seung Hwan Lee and 6 more

Abstract readReview
In one paragraph

Review in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Measurement of Hair Cortisol Throughout Gestation.Journal of clinical medicine · 2026
    Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

InWha ParkSchool of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.ORCID http://orcid.org/0009-0009-0669-7674
Hyokyeong GwonSchool of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.
Yeonjeong JungSchool of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.
Boyoung KimDepartment of Biopharmaceutical Convergence, Sungkyunkwan University, Suwon, Republic of Korea.
Gaeun JuDepartment of Biopharmaceutical Convergence, Sungkyunkwan University, Suwon, Republic of Korea.
Eugene SinDepartment of Pharmacology, School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.ORCID http://orcid.org/0009-0002-2808-8326
Hye In AnSchool of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.
Hye Jung BangDepartment of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, Republic of Korea.
Taegwan YunDepartment of Biopharmaceutical Convergence, Sungkyunkwan University, Suwon, Republic of Korea.ORCID http://orcid.org/0009-0005-6071-224X
Seung Hwan LeeDepartment of Biopharmaceutical Convergence, Sungkyunkwan University, Suwon, Republic of Korea.
Wonsik LeeSchool of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.ORCID http://orcid.org/0000-0001-9707-4513
Choon-Gon JangDepartment of Pharmacology, School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.
Hyo-Jong LeeSchool of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.ORCID http://orcid.org/0000-0003-4826-7954
Chung Sub KimSchool of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.ORCID http://orcid.org/0000-0001-9961-4093
Jeongmi LeeSchool of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea. jlee0610@skku.edu.ORCID http://orcid.org/0000-0002-9948-7554
Soah LeeSchool of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea. soahlee@skku.edu.ORCID http://orcid.org/0000-0001-7613-592X

Funding

Ministry of Food and Drug Safety (MFDS) 23212MFDS218National Research Foundation of Korea (NRF) 2021R1C1C1011045National Research Foundation of Korea (NRF) 2022R1A6A1A03054419National Research Foundation of Korea (NRF) RS-2024-00342554National Research Foundation of Korea (NRF) RS-2024-00350385
6 · The paper itself

Abstract

The study of complex diseases has traditionally relied on reductionist methods, which, although informative, tend to overlook the dynamic interactions and systemic interconnectivity inherent in biological systems. Allostasis, a framework that focuses on physiological adaptations to stress and the maintenance of stability through change, provides a valuable perspective for understanding these diseases. This review summarizes how the allostasis framework defines the cumulative physiological burden-known as allostatic load-imposed by chronic stressors such as persistent psychosocial pressure, drug abuse, and chronic infections. It also explores how adaptive physiological shifts, or changes in allostatic state, contribute to disorders, particularly drug addiction, immune diseases, and cancer. We then review recent studies that uncover stress adaptation mechanisms using cutting-edge technologies, such as multi-omics approaches, induced pluripotent stem cells (iPSCs), and organoid technology. This integrative approach, combining advanced technologies with the allostasis framework, can deepen our understanding of complex disease pathogenesis and inform the development of more effective diagnostic and therapeutic strategies.

Indexed as

AllostasisAdaptation, PhysiologicalAnimalsHumansInduced Pluripotent Stem Cells

Identifiers

PMID41193722
PMCPMC12589452

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.